Abalos was founded to translate an innovative immuno-virotherapy approach into novel anti-cancer therapies
Dr. Marcus Kostka
CEO
Location: Germany, North Rhine-Westphalia, Dusseldorf
Total raised: $63.16M
Investors 3
| Date | Name | Website |
| - | Coparion | coparion.v... |
| - | Gründerfon... | gruenderfo... |
| - | High-Tech ... | htgf.de |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 14.10.2021 | Series A | $49.92M | - |
| 15.10.2019 | Series A | $13.24M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 15.10.2021 | Abalos Therapeutics Raises €32.5M in Series A Extension | Abalos Therapeutics, a Dusseldorf, Germany-based company harnessing arenaviruses in a differentiated... | finsmes.co... |
| 14.10.2021 | Abalos Therapeutics : Completes Series A Extension Bringing ... | Abalos Therapeutics announced today an extension to its Series A funding round bringing the total ra... | marketscre... |
| 14.10.2021 | Abalos Therapeutics Completes Series A Extension Bringing To... | Additional EUR 32.5 million will support clinical readiness and accelerate lead immuno-virotherapy c... | seventure.... |
| 15.10.2019 | Abalos Therapeutics Raises €12M in Series A Funding | Abalos Therapeutics, an Essen, Germany-based developer of novel immuno-virotherapies against cancer,... | finsmes.co... |
| - | Abalos Therapeutics Launches with €12M Series A Round to Dev... | October 15, 2019 Abalos Therapeutics announced today a EUR 12 million Series A financing round esta... | htgf.de/en... |
| - | Abalos Therapeutics Completes Series A Extension Bringing To... | October 14, 2021 Additional EUR 32.5 million will support clinical readiness and accelerate lead im... | htgf.de/en... |